Showing results (391-400 of 429) with videos related to
Sort By:
Pageof 43
Cellular and Molecular Life Sciences : CMLS|August 11, 2022
Activation of non-classical NMDA receptors by glycine impairs barrier function of brain endothelial cellsLisa Epping, Christina B Schroeter, Christopher Nelke, et al.Therapeutic Advances in Neurological Disorders|August 1, 2026
Impact of tobacco and alcohol consumption on disease progression and MRI in people with multiple sclerosis: results of the prospective cohort study NationMSAlex Maximilian Keller, Annika Möhl, Anke Salmen, et al.JAMA Neurology|June 2, 2025
Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated SyndromeNicolás Fissolo, Sabine Schaedelin, Luisa M Villar, et al.Nature Medicine|August 13, 2013
Endothelial TWIK-related potassium channel-1 (TREK1) regulates immune-cell trafficking into the CNSStefan Bittner, Tobias Ruck, Michael K Schuhmann, et al.Cells|January 16, 2020
The Rare IL22RA2 Signal Peptide Coding Variant rs28385692 Decreases Secretion of IL-22BP Isoform-1, -2 and -3 and Is Associated with Risk for Multiple SclerosisPaloma Gómez-Fernández, Aitzkoa Lopez de Lapuente Portilla, Ianire Astobiza, et al.Neurogenetics|March 19, 2014
Assessment of microRNA-related SNP effects in the 3' untranslated region of the IL22RA2 risk locus in multiple sclerosisChristina M Lill, Marcel Schilling, Sara Ansaloni, et al.Journal of Neurology|December 6, 2018
Can we predict cognitive decline after initial diagnosis of multiple sclerosis? Results from the German National early MS cohort (KKNMS)Andreas Johnen, Paul-Christian Bürkner, Nils C Landmeyer, et al.Neurology(R) Neuroimmunology & Neuroinflammation|March 8, 2018
Treatment choices and neuropsychological symptoms of a large cohort of early MSOlga von Bismarck, Theresa Dankowski, Björn Ambrosius, et al.Proceedings of the National Academy of Sciences of the United States of America|February 23, 2021
Cross-reactivity of a pathogenic autoantibody to a tumor antigen in GABAA receptor encephalitisSimone M Brändle, Manuela Cerina, Susanne Weber, et al.Science Translational Medicine|January 21, 2026
In silico screening and preclinical validation identify bavisant as a therapeutic candidate for multiple sclerosisNadjet Gacem, Svetlana Bezukladova, Farina Windener, et al.Pageof 43